← Insider buys
CRNX

Crinetics Pharmaceuticals, Inc. · Healthcare

Director Coelho Rogerio Vivaldi sold $120K of Crinetics Pharmaceuticals, Inc.

Sold$120,000
$40.00Price
3,000Shares
−13%Stake

What CRNX did after the filing

Filed Jul 7Copier in Jul 8
The stock from Wed, Jul 8 open, $83.52
+1.4%
S&P 500, same days
+2.6%

Measured over 30 trading days, to the Aug 20 close.

Traded Thu, Jul 2. Filed Tue, Jul 7, 4:30 PM ET, after the close. Returns use the Jul 8 open and the Aug 20 close. Not investment advice.